One hundred former NFL players, including Pro Football Hall of Famers, are among the participants in a study evaluating the efficacy and safety of PRO-IV Chronic Pain DripFusion Therapy.
Preliminary data from the study will be released in early February in Houston, which is the host city for the upcoming Super Bowl.
PRO-IV Chronic Pain DripFusion Therapy is an IV-driven anti-opioid, anti-steroid, minimally invasive therapy involving Micronutrients and an algorithm of FDA-approved pharmaceuticals to remove inflammation, explains a media release from PRO-IV.
The study will be led by Dr Kevin Jackson, MD, a Chicago-based board-certified neurosurgeon along with DripFusion Chief Medical Officer Dr Kevin Wiltz, PharmD, PRS.
“I have invested a considerable amount of my life’s worth, both financially and more importantly, relationally because we believe we are doing what is right and we will treat as many players for free as our limited resources will allow,” states PRO-IV co-founder, former NFL pro, and NFL network analyst Jamie Dukes, in the release.
Dukes heads PRO-IV along with former NFL GM Ray Farmer. Pro Football Hall of Famer Deion Sanders, NFL All-Pros Ray Lewis, Deangelo Hall, and Randy Cross, as well as pro wrestler Bill Goldberg join them as advocates of PRO-IV Infusion Therapy.
Former Major League Baseball and National Basketball Association players will also participate in the study, the release states.
[Source(s): PRO-IV, PR Newswire]
